Proanthocyanidin A2 attenuates the activation of hepatic stellate cells by activating the PPAR-γ signalling pathway

References

• Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:1–7.
   PubMed Web of Science ®Google Scholar
• Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9(4):875.
   PubMed Web of Science ®Google Scholar
• Altamirano-Barrera A, Barranco-Fragoso B, Méndez-Sánchez N. Management strategies for liver fibrosis. Ann Hepatol. 2017;16(1):48–56.
   PubMed Web of Science ®Google Scholar
• Campos-Murguía A, Ruiz-Margáin A, González-Regueiro JA, et al. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol. 2020;26(39):5919–5943.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151–166.
   PubMed Web of Science ®Google Scholar
• Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017; 121:27–42.
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425–456.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wu Q, Chen Y, et al. Inhibition of proanthocyanidin A2 on porcine reproductive and respiratory syndrome virus replication in vitro. PLoS One. 2018;13(2):e0193309.
   PubMed Web of Science ®Google Scholar
• Yang DJ, Chang YZ, Chen YC, et al. Antioxidant effect and active components of litchi (Litchi chinensis sonn.) flower. Food Chem Toxicol. 2012;50(9):3056–3061.
   PubMed Web of Science ®Google Scholar
• Lin JT, Chang YY, Chen YC, et al. Litchi (Litchi chinensis sonn.) flower proanthocyanidin fraction exhibited protective efficacy to suppress nickel-induced expression for vascular endothelial growth factor in HepG2 cells. J Food Biochem. 2019;43(7):e12882.
   PubMed Web of Science ®Google Scholar
• Zhang L, Shao J, Zhou Y, et al. Inhibition of PDGF-BB-induced proliferation and migration in VSMCs by proanthocyanidin A2: involvement of KDR and jak-2/STAT-3/cPLA2 signaling pathways. Biomed Pharmacother. 2018;98:847–855.
   PubMed Web of Science ®Google Scholar
• Gallina L, Dal Pozzo F, Galligioni V, et al. Inhibition of viral RNA synthesis in canine distemper virus infection by proanthocyanidin A2. Antiviral Res. 2011;92(3):447–452.
   PubMed Web of Science ®Google Scholar
• Ma Q, Xie H, Li S, et al. Flavonoids from the pericarps of Litchi chinensis. J Agric Food Chem. 2014;62(5):1073–1078.
   PubMed Web of Science ®Google Scholar
• Xu X, Xie H, Wang Y, et al. A-type proanthocyanidins from lychee seeds and their antioxidant and antiviral activities. J Agric Food Chem. 2010;58(22):11667–11672.
   PubMed Web of Science ®Google Scholar
• Korbecki J, Bobiński R, Dutka M. Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors. Inflamm Res. 2019;68(6):443–458.
   PubMed Web of Science ®Google Scholar
• Wagner N, Wagner KD. The role of PPARs in disease. Cells. 2020;9(11):2367.
   PubMed Web of Science ®Google Scholar
• Li H, Yang M. Ligustrazine activate the PPAR-γ pathway and play a protective role in vascular calcification. Vascular. 2022;30(6):1224–1231.
   PubMed Web of Science ®Google Scholar
• Prashantha Kumar BR, Kumar AP, Jose JA, et al. Minutes of PPAR-γ agonism and neuroprotection. Neurochem Int. 2020;140:104814.
   PubMed Web of Science ®Google Scholar
• Han X, Wu Y, Yang Q, et al. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacol Ther. 2021;222:107791.
   PubMed Web of Science ®Google Scholar
• de Souza Basso B, Haute GV, Ortega-Ribera M, et al. Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-ɣ and NF-kB mechanism. J Ethnopharmacol. 2021;280:114433.
   PubMed Web of Science ®Google Scholar
• Yu Q, Cheng P, Wu J, et al. PPARγ/NF-κB and TGF-β1/smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. J Cell Mol Med. 2021;25(3):1645–1660.
   PubMed Web of Science ®Google Scholar
• Zhao C, Chen W, Yang L, et al. PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells. Biochem Biophys Res Commun. 2006;350(2):385–391.
   PubMed Web of Science ®Google Scholar
• Mu M, Zuo S, Wu RM, et al. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/smad signaling pathway. Drug Des Devel Ther. 2018;12:4107–4115.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Ashfaq-Khan M, Yang AT, et al. Liver fibrosis: direct antifibrotic agents and targeted therapies. Matrix Biol. 2018;68-69:435–451.
   PubMed Web of Science ®Google Scholar
• Nicolosi D, Tempera G, Genovese C, et al. Anti-adhesion activity of A2-type proanthocyanidins (a cranberry major component) on uropathogenic E. coli and P. mirabilis strains. Antibiotics. 2014;3(2):143–154.
   Google Scholar
• Coleman SL, Kruger MC, Sawyer GM, et al. Procyanidin A2 modulates IL-4-Induced CCL26 production in human alveolar epithelial cells. Int J Mol Sci. 2016;17(11):1888.
   PubMed Web of Science ®Google Scholar
• Wang QQ, Gao H, Yuan R, et al. Procyanidin A2, a polyphenolic compound, exerts anti-inflammatory and anti-oxidative activity in lipopolysaccharide-stimulated RAW264.7 cells. PLoS One. 2020;15(8):e0237017.
   PubMed Web of Science ®Google Scholar
• Oldoni TL, Melo PS, Massarioli AP, et al. Bioassay-guided isolation of proanthocyanidins with antioxidant activity from peanut (Arachis hypogaea) skin by combination of chromatography techniques. Food Chem. 2016;192:306–312.
   PubMed Web of Science ®Google Scholar
• Sintara M, Wang Y, Li L, et al. Quantification of cranberry proanthocyanidins by normal-phase high-performance liquid chromatography using relative response factors. Phytochem Anal. 2020;31(6):874–883.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li H, Zhang S, et al. Anti-myocardial ischemia effect and components of litchi pericarp extracts. Phytother Res. 2017;31(9):1384–1391.
   PubMed Web of Science ®Google Scholar
• Sui Y, Zheng Y, Li X, et al. Characterization and preparation of oligomeric procyanidins from litchi chinensis pericarp. Fitoterapia. 2016;112:168–174.
   PubMed Web of Science ®Google Scholar
• Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397–411.
   PubMed Web of Science ®Google Scholar
• Chyau CC, Wang HF, Zhang WJ, et al. Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL/6 mice model via AMPK/Sirt1/SREBP-1c/PPARγ pathway. Int J Mol Sci. 2020;21(1):360.
   PubMed Web of Science ®Google Scholar
• Kersten S, Stienstra R. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. Biochimie. 2017;136:75–84.
   PubMed Web of Science ®Google Scholar
• Ni XX, Li XY, Wang Q, et al. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/smad signaling pathway. J Physiol Biochem. 2021;77(1):35–45.
   PubMed Web of Science ®Google Scholar
• Li J, Guo C, Wu J. The agonists of peroxisome proliferator-activated receptor-γ for liver fibrosis. Drug Des Devel Ther. 2021;15:2619–2628.
   PubMed Web of Science ®Google Scholar
• Hu HH, Chen DQ, Wang YN, et al. New insights into TGF-β/smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76–83.
   PubMed Web of Science ®Google Scholar
• Xiang D, Zou J, Zhu X, et al. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/smad and Yap signaling. Phytomedicine. 2020;78:153294.
   PubMed Web of Science ®Google Scholar